Woodline Partners LP Immunity Bio, Inc. Transaction History
Woodline Partners LP
- $13.5 Billion
- Q4 2024
A detailed history of Woodline Partners LP transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Woodline Partners LP holds 3,442,440 shares of IBRX stock, worth $12.5 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
3,442,440
Previous 439,818
682.7%
Holding current value
$12.5 Million
Previous $1.63 Million
440.28%
% of portfolio
0.07%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding IBRX
# of Institutions
226Shares Held
77.8MCall Options Held
1.73MPut Options Held
1.92M-
Vanguard Group Inc Valley Forge, PA17.3MShares$62.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$41.4 Million0.0% of portfolio
-
State Street Corp Boston, MA9.79MShares$35.4 Million0.0% of portfolio
-
Morgan Stanley New York, NY4.01MShares$14.5 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.84MShares$13.9 Million0.0% of portfolio
About ImmunityBio, Inc.
- Ticker IBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 400,304,000
- Market Cap $1.45B
- Description
- ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...